Taro-doxorubicin Liposomal: May Contain Particulate Matter
Taro-Doxorubicin Liposomal is being recalled across Canada because some batches may contain particulate matter (solid particles) in the medication. This is a Class I recall, meaning the product could cause serious health problems. The recall affects all Taro-Doxorubicin Liposomal distributed in Canada.
- Product
- Taro-Doxorubicin Liposomal
- Reason
- Product quality
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2025-07-11
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/6d855026-370a-44be-9d28-3f9b10c62622